Abstract
This paper addresses disputes in the transplantation of tissues from transgenic animals to humans (XTP) between a number of biotech firms and several UK-based animal advocacy groups. Debates centre on the management of human and non-human identity, the indeterminacies of therapeutic efficacy and the risks of trans- species disease. Both constituencies make use of moral/cultural and scientific repertoires to advance their arguments.Science and Technology Studies treatments of the dynamics between scientific institutions and pressure group Non-governmental organizations tend to emphasize the epistemological privileges of the former over the latter. However, the XTP case highlights a strategic flexibility enabling animal advocacy groups to deploy social and scientific arguments that are fundamentally contradictory. Such contradictions are much more difficult for scientific institutions to maintain, given the rigidities of the material and symbolic resources from which they derive their expertise in the first place.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
